Daiichi Sankyo Obtains Approval For Flu Drug Laninamivir
This article was originally published in PharmAsia News
Executive Summary
Japanese regulators Sept. 10 approved Daiichi Sankyo's long-acting flu drug Inavir (laninamivir) inhalation powder 20mg